Literature DB >> 11950330

A high-throughput screening protocol for fast evaluation of enantioselective catalysts.

Christian Wolf1, Pili A Hawes.   

Abstract

A new high-throughput screening protocol that allows fast evaluation of enantioselective catalysts has been developed. The usefulness of norephedrine-derived beta-amino alcohols as catalysts for the enantioselective alkylation of prochiral aldehydes has been determined by simultaneous screening of three representative substrates. GC analysis of the crude product mixture using a selectively modified cyclodextrin as the chiral stationary phase avoids time-consuming workup procedures. The chemical yield, enantioselectivity, substrate specificity, and catalytic activity of the chiral catalysts as well as the induced absolute configuration have been determined in a single screening experiment and two short GC runs.

Entities:  

Year:  2002        PMID: 11950330     DOI: 10.1021/jo025534s

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  High-throughput screening of identity, enantiomeric excess, and concentration using MLCT transitions in CD spectroscopy.

Authors:  Sonia Nieto; Vincent M Lynch; Eric V Anslyn; Hyunwoo Kim; Jik Chin
Journal:  J Am Chem Soc       Date:  2008-06-24       Impact factor: 15.419

2.  A facile circular dichroism protocol for rapid determination of enantiomeric excess and concentration of chiral primary amines.

Authors:  Sonia Nieto; Justin M Dragna; Eric V Anslyn
Journal:  Chemistry       Date:  2010-01-04       Impact factor: 5.236

3.  Rapid enantiomeric excess and concentration determination using simple racemic metal complexes.

Authors:  Sonia Nieto; Vincent M Lynch; Eric V Anslyn; Hyunwoo Kim; Jik Chin
Journal:  Org Lett       Date:  2008-10-22       Impact factor: 6.005

4.  Miniature high-throughput chemosensing of yield, ee, and absolute configuration from crude reaction mixtures.

Authors:  Keith W Bentley; Peng Zhang; Christian Wolf
Journal:  Sci Adv       Date:  2016-02-12       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.